Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Startup leaders are actively engaging with federal regulators in Washington, D.C., as new AI rules are being considered to ensure patient safety. These leaders are concerned that the regulations might favor large corporations and create obstacles for smaller health tech startups. Accelerators and venture capital firms, such as Y Combinator and Andreessen Horowitz, are advocating for the interests of smaller tech companies. The involvement of these entities underscores the significance of the ongoing discussions about AI regulations in the healthcare sector, as reported by @statnews and @ravindranize.
As Washington mulls new AI rules, startup leaders want a seat at the table https://t.co/UX5ky8sa3X via @statnews @ravindranize
Accelerators & VC firms w/growing health investments, like @ycombinator & @a16z, are flying the "little tech" flag as Congress/White House mull AI rules. A look at their fight for a seat at the table in Washington: https://t.co/ar5zHYz8Cf
As federal regulators try protect patients from being harmed by AI, health tech startups are doing the rounds in D.C. to make sure new rules don't favor large corporations or create hurdles for startups, @ravindranize reports https://t.co/5h6T71mXPY via @statnews
